0 Bedömningar
ID

42958

Beskrivning

Nyckelord

Versioner (4)
  1. 2011-11-11 2011-11-11 -
  2. 2011-11-11 2011-11-11 -
  3. 2014-03-21 2014-03-21 - Martin Dugas
  4. 2021-09-17 2021-09-17 -
Uppladdad den

17 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Eligibility Criteria NCT00044564

    Engelsk

    Eligibility

    1 Formulär  
    1. StudyEvent: Eligibility
      1. Eligibility
    Inclusion criteria
    Beskrivning

    Inclusion criteria

    Alias
    UMLS CUI
    C1512693
    measurable disease as defined by the presence of at least one measurable lesion
    Beskrivning

    Advanced Renal Cell Carcinoma

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0007134
    prior immunotherapy (up to 2 regimens) or prior radiotherapy is permitted but at least 4 weeks must have elapsed prior to enter study
    Beskrivning

    Prior immunotherapy or radiotherapy

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0021083
    UMLS CUI-2
    C1522449
    life expectancy of at least 12 weeks
    Beskrivning

    Life expectancy

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0023671
    adequate bone marrow, liver and kidney function
    Beskrivning

    Bone marrow, liver, kidney

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0023508
    UMLS CUI-2
    C1287267
    UMLS CUI-3
    C0019046
    UMLS CUI-4
    C0525032
    UMLS CUI-5
    C0011221
    UMLS CUI-6
    C0010294
    Exclusion criteria
    Beskrivning

    Exclusion criteria

    Alias
    UMLS CUI
    C0680251
    excluded medical conditions like: pre-existing neuropathy, active heart diseases or ischemia, serious infections, HIV infection, chronic hepatitis B or C, brain metastasis, seizures, hypersensitivity to taxanes, organ transplants, some previous cancers
    Beskrivning

    excluded medical conditions

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0442874
    UMLS CUI-2
    C0018799
    UMLS CUI-3
    C0009450
    UMLS CUI-4
    C0019693
    UMLS CUI-5
    C0019158
    UMLS CUI-6
    C0220650
    UMLS CUI-7
    C0036572
    UMLS CUI-8
    C0274302
    UMLS CUI-9
    C0029216
    UMLS CUI-10
    C0006826
    excluded therapies and medications, previous and concomitant such as: anticancer chemotherapy or immunotherapy during the study or within 4 weeks prior to study entry; more than two prior anticancer chemotherapy regimens; radiotherapy during study or within 4 weeks prior to study entry; bone marrow transplant
    Beskrivning

    excluded therapies and medications

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0392920
    UMLS CUI-2
    C1963758
    UMLS CUI-3
    C1522449
    UMLS CUI-4
    C0005961
    others: pregnant or breast-feeding patients; both men and women enrolled in this trial must use adequate barrier birth control measures during the course of the trial; substance abuse, medical, psychological or social conditions that may interfere with the patient's participation
    Beskrivning

    other exclusion criteria

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0549206
    UMLS CUI-2
    C0006147
    UMLS CUI-3
    C2919192
    UMLS CUI-4
    C0013146
    UMLS CUI-5
    C0376405
    Tillbaka till toppen

    Similar models

    Eligibility

    1 Formulär
    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Inclusion criteria
    C1512693 (UMLS CUI)
    Advanced Renal Cell Carcinoma
    Item
    measurable disease as defined by the presence of at least one measurable lesion
    boolean
    C0007134 (UMLS CUI-1)
    Prior immunotherapy or radiotherapy
    Item
    prior immunotherapy (up to 2 regimens) or prior radiotherapy is permitted but at least 4 weeks must have elapsed prior to enter study
    boolean
    C0021083 (UMLS CUI-1)
    C1522449 (UMLS CUI-2)
    Life expectancy
    Item
    life expectancy of at least 12 weeks
    boolean
    C0023671 (UMLS CUI-1)
    Bone marrow, liver, kidney
    Item
    adequate bone marrow, liver and kidney function
    boolean
    C0023508 (UMLS CUI-1)
    C1287267 (UMLS CUI-2)
    C0019046 (UMLS CUI-3)
    C0525032 (UMLS CUI-4)
    C0011221 (UMLS CUI-5)
    C0010294 (UMLS CUI-6)
    Item Group
    Exclusion criteria
    C0680251 (UMLS CUI)
    excluded medical conditions
    Item
    excluded medical conditions like: pre-existing neuropathy, active heart diseases or ischemia, serious infections, HIV infection, chronic hepatitis B or C, brain metastasis, seizures, hypersensitivity to taxanes, organ transplants, some previous cancers
    boolean
    C0442874 (UMLS CUI-1)
    C0018799 (UMLS CUI-2)
    C0009450 (UMLS CUI-3)
    C0019693 (UMLS CUI-4)
    C0019158 (UMLS CUI-5)
    C0220650 (UMLS CUI-6)
    C0036572 (UMLS CUI-7)
    C0274302 (UMLS CUI-8)
    C0029216 (UMLS CUI-9)
    C0006826 (UMLS CUI-10)
    excluded therapies and medications
    Item
    excluded therapies and medications, previous and concomitant such as: anticancer chemotherapy or immunotherapy during the study or within 4 weeks prior to study entry; more than two prior anticancer chemotherapy regimens; radiotherapy during study or within 4 weeks prior to study entry; bone marrow transplant
    boolean
    C0392920 (UMLS CUI-1)
    C1963758 (UMLS CUI-2)
    C1522449 (UMLS CUI-3)
    C0005961 (UMLS CUI-4)
    other exclusion criteria
    Item
    others: pregnant or breast-feeding patients; both men and women enrolled in this trial must use adequate barrier birth control measures during the course of the trial; substance abuse, medical, psychological or social conditions that may interfere with the patient's participation
    boolean
    C0549206 (UMLS CUI-1)
    C0006147 (UMLS CUI-2)
    C2919192 (UMLS CUI-3)
    C0013146 (UMLS CUI-4)
    C0376405 (UMLS CUI-5)
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial